Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-3-23
pubmed:abstractText
Cathepsin K (EC 3.4.22.38), a cysteine protease of the papain superfamily, is predominantly expressed in osteoclasts and has been postulated as a target for the treatment of osteoporosis. Crystallographic and structure--activity studies on a series of acyclic ketone-based inhibitors of cathepsin K have led to the design and identification of two series of cyclic ketone inhibitors. The mode of binding for four of these cyclic and acyclic inhibitors to cathepsin K is discussed and compared. All of the structures are consistent with addition of the active site thiol to the ketone of the inhibitors with the formation of a hemithioketal. Cocrystallization of the C-3 diastereomeric 3-amidotetrahydrofuran-4-one analogue 16 with cathepsin K showed the inhibitor to occupy the unprimed side of the active site with the 3S diastereomer preferred. This C-3 stereochemical preference is in contrast to the X-ray cocrystal structures of the 3-amidopyrrolidin-4-one inhibitors 29 and 33 which show these inhibitors to prefer binding of the 3R diastereomer. The 3-amidopyrrolidin-4-one inhibitors were bound in the active site of the enzyme in two alternate directions. Epimerization issues associated with the labile alpha-amino ketone diastereomeric center contained within these inhibitor classes has proven to limit their utility despite promising pharmacokinetics displayed in both series of compounds.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
725-36
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11262083-Animals, pubmed-meshheading:11262083-Binding Sites, pubmed-meshheading:11262083-Cathepsin K, pubmed-meshheading:11262083-Cathepsins, pubmed-meshheading:11262083-Chromatography, Liquid, pubmed-meshheading:11262083-Crystallography, X-Ray, pubmed-meshheading:11262083-Enzyme Inhibitors, pubmed-meshheading:11262083-Furans, pubmed-meshheading:11262083-Humans, pubmed-meshheading:11262083-Ketones, pubmed-meshheading:11262083-Mass Spectrometry, pubmed-meshheading:11262083-Models, Molecular, pubmed-meshheading:11262083-Molecular Structure, pubmed-meshheading:11262083-Piperidines, pubmed-meshheading:11262083-Pyrans, pubmed-meshheading:11262083-Pyrrolidinones, pubmed-meshheading:11262083-Rats, pubmed-meshheading:11262083-Stereoisomerism, pubmed-meshheading:11262083-Structure-Activity Relationship
pubmed:year
2001
pubmed:articleTitle
Cyclic ketone inhibitors of the cysteine protease cathepsin K.
pubmed:affiliation
Department of Medicinal Chemistry, GlaxoSmithKline, King of Prussia, Pennsylvania 19406, USA. Robert_W_Marquis@sbphrd.com
pubmed:publicationType
Journal Article